U.S. Compounding Pharmacies Market, By Medication (Oral Medication(Capsules, Tablets, Mixtures, Lollipops, Lozenges),Topical Medication(Gels, Ointments, Cream, Lotions), Mouthwashes, Suppositories), By Therapeutic Area (Pain Management, Hormone Replacemen

U.S. Compounding Pharmacies Market, By Medication (Oral Medication(Capsules, Tablets, Mixtures, Lollipops, Lozenges),Topical Medication(Gels, Ointments, Cream, Lotions), Mouthwashes, Suppositories), By Therapeutic Area (Pain Management, Hormone Replacement Therapy (HRT)), By Application (Medication for Adults, Medication for Veterinary, Medication for Children, Medication for Geriatric) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Compounding pharmacies consist of creation/compounding of pharmaceutical products tailored to fit the needs of the patient. Compounding pharmacies is a type of personalized medicine and caters to specific needs of the patients. Compounding of pharmaceutical products presents as a solution for patients with problems such as inability to swallow pills, gluten allergy, short supply drugs, and others. Patients having allergies associated with commonly used medicine fillers such as casein, gluten, and dyes can be avoided in compounding pharmacy as you can avoid use of such components. Compounding pharmacy solutions providers, and companies are indulged in research and development of novel treatment options with the use of advanced technology. For instance, TOMI Environmental Solutions, Inc. (company specializing in disinfection and decontamination) has implemented its SteraMist iHP technology in multiple compounding pharmacies in December 2019 to adhere to USP 795, USP 797, USP 800, and Good Manufacturing Practices (GMP) standards. These factors are expected to support U.S. compounding pharmacies market growth over the forecast period.
Restraints of the U.S. Compounding Pharmacies Market
One of the major restraints of this market is that these products are not approved by U.S. Food & Drug Administration (FDA). Moreover, recently in November 2019, a study results of sampling of levothyroxine (LT4) liquid formulations obtained from compounding pharmacies were highlighted at American Thyroid Association (ATA) 89th Annual Meeting. Results showed substantial variation in the active drug components of such products, which could be a health risk. These factors are expected to restrain growth of the market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the U.S. compounding pharmacies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the U.S. compounding pharmacies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Avella Specialty Pharmacy, Fagron N.V., Central Admixture Pharmacy Services, Inc., Wedgewood Pharma, Institutional Pharmacy Solutions, Lorraine’s Pharmacy, PharMEDium Services LLC, Village Compounding Pharmacy, Triangle Compounding Pharmacy, and Vertisis Custom Pharmacy
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The U.S. compounding pharmacies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the assistive reproductive technology market.
Detailed Segmentation
U.S. Compounding Pharmacies Market, By Medication:
Oral Medication
Capsules
Tablets
Mixtures
Lollipops
Lozenges
Topical Medication
Gels
Ointments
Cream
Lotions
Mouthwashes
Suppositories
U.S. Compounding Pharmacies Market, By Therapeutic Area:
Pain Management
Hormone Replacement Therapy (HRT)
U.S. Compounding Pharmacies Market, By Application:
Medication for Adults
Medication for Veterinary
Medication for Children
Medication for Geriatric
Company Profiles
Avella Specialty Pharmacy *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Fagron N.V.
Central Admixture Pharmacy Services, Inc.
Wedgewood Pharma
Institutional Pharmacy Solutions
Lorraine’s Pharmacy
PharMEDium Services LLC
Village Compounding Pharmacy
Triangle Compounding Pharmacy
Vertisis Custom Pharmacy
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Medication
Market Snippet, By Therapeutic Area
Market Snippet, By Application
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Technological Advancement
Regulatory Scenario
4. U.S. Compounding Pharmacies Market, By Medication, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028(%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Oral Medication
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Capsules
Tablets
Mixtures
Lollipops
Lozenges
Topical Medication
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Gels
Ointments
Cream
Lotions
Mouthwashes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Suppositories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
5. U.S. Compounding Pharmacies Market, By Therapeutic Area, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028(%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Pain Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Hormone Replacement Therapy (HRT)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. U.S. Compounding Pharmacies Market, By Application, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028(%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Medication for Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Medication for Veterinary
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Medication for Children
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Medication for Geriatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Competitive Landscape
Heat Map Analysis
Company Profiles
Avella Specialty Pharmacy
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Fagron N.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Central Admixture Pharmacy Services, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Wedgewood Pharma
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Institutional Pharmacy Solutions
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Lorraine’s Pharmacy
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
PharMEDium Services LLC
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Village Compounding Pharmacy
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Triangle Compounding Pharmacy
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Vertisis Custom Pharmacy
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 37 market data tables and 25 figures on “Compounding Pharmacies Market – U.S. forecast to 2028.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings